Tua Tagovailoa


Age: 22
Free Agency: 2024 (UFA)
Accrued Seasons: 0
  • 2020 Salary Cap Charge: $5,504,625 (2.53% of cap)
  • 2020 Cash Payout: $20,188,500 (9.60% of spending)
  • 2020 Cash to Cap Ratio: 3.67
  • Contract Value: $30,275,436 ($7,568,859 APY)
  • Fully Guaranteed Money: $30,275,436
  • Contract Ranking: 27/107 at QB

Current Contract

(Drafted, signed 2020)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusGuaranteed SalaryCap
Cap %
Dead Money & Cap Savings
2021 📝
August 1: Training camp roster bonus due
2022 📝
August 1: Training camp roster bonus due
2023 📝
August 1: Training camp roster bonus due

Contract Notes

Tua Tagovailoa signed a four year, $30,275,436 contract with the Dolphins. Tagovailoa's entire contract is guaranteed and includes a signing bonus of $19,578,500.
Career Earnings: $19,578,500
Career APY: $0
Potential Earnings: $30,275,436
Total Guarantees: $30,275,436
Largest Cash Payment: $20,188,500 (2020)
Largest Cap Number: $9,633,093 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money


YearGames PlayedGames MissedSnapsPassingRushingFumbles

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Injury Adjusted$1,107,000$7,568,859
OTC Valuation $6.4M $12.8M $19.2M $25.6M $32.0M APY $7.5M $15.0M $22.5M $30.0M $37.5M $27,588,000 $25,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.